These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 25938126)

  • 1. Nitrous oxide consistently attenuates thermogenic and thermoperceptual responses to repetitive cold stress in humans.
    Moes MI; Elia A; Gennser M; Eiken O; Keramidas ME
    J Appl Physiol (1985); 2023 Sep; 135(3):631-641. PubMed ID: 37471214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual differences in biological regulation: Predicting vulnerability to drug addiction, obesity, and other dysregulatory disorders.
    Ramsay DS; Kaiyala KJ; Woods SC
    Exp Clin Psychopharmacol; 2020 Aug; 28(4):388-403. PubMed ID: 32338936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Signaling and the Dark Side of Addiction.
    Miles OW; May V; Hammack SE
    J Mol Neurosci; 2019 Jul; 68(3):453-464. PubMed ID: 30074172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma corticosterone, epinephrine, and norepinephrine levels increase during administration of nitrous oxide in rats.
    Al-Noori S; Cimpan A; Maltzer Z; Kaiyala KJ; Ramsay DS
    Stress; 2018 May; 21(3):274-278. PubMed ID: 29145764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unifying theory for the functional architecture of endothermic thermoregulation.
    Flouris AD
    Temperature (Austin); 2014; 1(3):162-3. PubMed ID: 27624651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature in the spotlight of drug abuse research.
    Carvalho F; Kiyatkin EA; Rusyniak DE; Romanovsky AA
    Temperature (Austin); 2015; 2(1):27-8. PubMed ID: 27226999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting addictive vulnerability: individual differences in initial responding to a drug's pharmacological effects.
    Ramsay DS; Al-Noori S; Shao J; Leroux BG; Woods SC; Kaiyala KJ
    PLoS One; 2015; 10(4):e0124740. PubMed ID: 25880426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced regulatory overcompensation has motivational consequences: Implications for homeostatic and allostatic models of drug addiction.
    Ramsay DS; Woods SC; Kaiyala KJ
    Temperature (Austin); 2014; 1(3):248-256. PubMed ID: 25938126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated nitrous oxide exposure in rats causes a thermoregulatory sign-reversal with concurrent activation of opposing thermoregulatory effectors.
    Ramsay DS; Woods SC; Kaiyala KJ
    Temperature (Austin); 2014; 1(3):257-267. PubMed ID: 25938127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-related metabolic rate and behavioral thermoregulatory adaptations to serial administrations of nitrous oxide in rats.
    Kaiyala KJ; Ramsay DS
    PLoS One; 2018; 13(4):e0194794. PubMed ID: 29672605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brown adipose tissue thermogenesis does not explain the intra-administration hyperthermic sign-reversal induced by serial administrations of 60% nitrous oxide to rats.
    Al-Noori S; Ramsay DS; Cimpan A; Maltzer Z; Zou J; Kaiyala KJ
    J Therm Biol; 2016 Aug; 60():195-203. PubMed ID: 27503733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of a hyperthermic sign-reversal during nitrous oxide inhalation despite cue-exposure treatment with and without a drug-onset cue.
    Kaiyala KJ; Woods SC; Ramsay DS
    Temperature (Austin); 2014; 1(3):268-275. PubMed ID: 25938128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrous oxide: What do we know about its use disorder potential? Results of the French Monitoring Centre for Addiction network survey and literature review.
    Fidalgo M; Prud'homme T; Allio A; Bronnec M; Bulteau S; Jolliet P; Victorri-Vigneau C
    Subst Abus; 2019; 40(1):33-42. PubMed ID: 30913001
    [No Abstract]   [Full Text] [Related]  

  • 14. Recreational nitrous oxide use: Prevalence and risks.
    van Amsterdam J; Nabben T; van den Brink W
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):790-6. PubMed ID: 26496821
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.